Darya-Varia Laboratoria Tbk PT operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Darya-Varia Laboratoria Tbk PT with three other
pharmaceutical manufacturers in Asia:
Biofermin Pharmaceutical Company Limited
sales of 10.85 billion Japanese Yen [US$97.39 million]
of which 59%
was New BioferminS),
Hyundai Pharmaceutical Company Limited
of South Korea
(109.83 billion Korean Won [US$98.30 million]
of which 85%
was Pharmaceutical), and
Zhejiang Jolly Pharmaceutical Co Ltd
based in China
(670.86 million Chinese Renmimbi [US$97.45 million]
of which 82%
During the year ended December of 2015, sales at
Darya-Varia Laboratoria Tbk PT were 1.31 trillion Indonesian Rupiahs (US$97.96 million).
increase of 18.3%
versus 2014, when the company's sales were 1.10 trillion Indonesian Rupiahs.
This was the fifth consecutive year of sales increases at Darya-Varia Laboratoria Tbk PT
(and since 2010, sales have increased a total of 41%).
Sales of Consumer Health saw an increase
that was more than double the company's growth rate: sales were up
40.6% in 2015, from
309.12 billion Indonesian Rupiahs to 434.58 billion Indonesian Rupiahs.
Darya-Varia Laboratoria Tbk PT also saw significant increases in sales in
Toll Manufacturing (up 24.9% to 291.62 billion Indonesian Rupiahs)